410 Medical Overview

  • Founded
  • 2013

Founded
  • Status
  • Private

  • Employees
  • 34

Employees
  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $3.09M

  • Investors
  • 13

410 Medical General Information

Description

Developer of a rapid infuser device designed to help critically ill patients requiring volume resuscitation. The company's device enhances the speed and efficiency of fluid resuscitation, improves care for patients with life-threatening illnesses such as sepsis and shock, enabling health care providers to easily deliver blood, blood components, crystalloids or colloid fluids.

Contact Information

Formerly Known As
410 Medical Innovation
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Devices and Supplies
Primary Office
  • 201 West Main Street
  • Suite 207
  • Durham, NC 27701
  • United States
+1 (919) 000-0000

410 Medical Timeline

2019202020212022
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

410 Medical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC 29-Dec-2021 $3.09M 000.00 Completed Generating Revenue
5. Debt - PPP 28-Apr-2020 000.00 Completed Generating Revenue
4. Later Stage VC (Series A) 22-Oct-2019 000.00 000.00 000.00 Completed Generating Revenue
3. Later Stage VC 22-Aug-2018 00.00 00.00 Completed Generating Revenue
2. Early Stage VC (Series A) 29-Jun-2017 $5.35M $6.45M 000.00 Completed Generating Revenue
1. Seed Round 13-Jan-2015 $1.1M $1.1M 00.00 Completed Generating Revenue
To view 410 Medical’s complete valuation and funding history, request access »

410 Medical Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A2 00,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series A1 0,000,000 00.000000 00 00.00 00.00 00 00.00 0.000
Seed 835,731 $0.001000 8% $1.46 $1.46 1x $1.46 0.98%
To view 410 Medical’s complete cap table history, request access »

410 Medical Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of a rapid infuser device designed to help critically ill patients requiring volume resuscitation. The company
Other Devices and Supplies
Durham, NC
34 As of 2022
000.00
0000000000 0 000.00

000000

eprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat
00000000 0000000
Athens, TX
000 As of 0000
000000&0

000000

equat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla
0000000000 000000000
Berlin, Germany
0000 As of 0000
0000 0000-00-00
000000&0
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

410 Medical Competitors (2)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
FutureMatrix Interventional Formerly PE-Backed Athens, TX 000 000000&0
000000000 Corporate Backed or Acquired Berlin, Germany 0000 000000&0
You’re viewing 2 of 2 competitors. Get the full list »

410 Medical Patents

410 Medical Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3836985-A4 Systems, apparatus, and methods for reducing fluid pressure in a fluid line Pending 13-Aug-2018 00000000 0
US-10871788-B2 Systems, apparatus, and methods for reducing fluid pressure in a fluid line Active 13-Aug-2018 00000000000
AU-2019321418-A1 Systems, apparatus, and methods for reducing fluid pressure in a fluid line Pending 13-Aug-2018 00000000000
US-20210325916-A1 Systems, apparatus, and methods for reducing fluid pressure in a fluid line Pending 13-Aug-2018 00000000000
EP-3836985-A1 Systems, apparatus, and methods for reducing fluid pressure in a fluid line Pending 13-Aug-2018 G05D16/0655
To view 410 Medical’s complete patent history, request access »

410 Medical Executive Team (7)

Name Title Board Seat Contact Info
Kyle Chenet Chief Executive Officer, President & Board Member
Galen Robertson Chief Operating Officer
Kim Clark Controller
Mark Piehl MD Co-Founder, Chief Medical Officer & Board Member
Lukas Roush Co-Founder & Board Member
You’re viewing 5 of 7 executive team members. Get the full list »

410 Medical Board Members (9)

Name Representing Role Since
Daniel Duffy Self Board Member 000 0000
Jeff Terrell Hatteras Venture Partners Board Member 000 0000
Kyle Chenet 410 Medical Chief Executive Officer, President & Board Member 000 0000
Lukas Roush Self Co-Founder & Board Member 000 0000
Mark Piehl MD 410 Medical Co-Founder, Chief Medical Officer & Board Member 000 0000
You’re viewing 5 of 9 board members. Get the full list »

410 Medical Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

410 Medical Investors (13)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Sea Purity Investments Family Office Minority 000 0000 000000 0
Hatteras Venture Partners Venture Capital Minority 000 0000 000000 0
OSF Ventures Corporate Venture Capital Minority 000 0000 000000 0
Collective Capital Ventures Venture Capital Minority 000 0000 000000 0
Kleinheinz Capital Partners Hedge Fund Minority 000 0000 000000 0
You’re viewing 5 of 13 investors. Get the full list »